|
| 37385974 | Stricker Learning Span criterion validity: a remote self-administered multi-device compatible digital word list memory measure shows similar ability to differentiate amyloid and tau PET-defined biomarker groups as in-person Auditory Verbal Learning Test. | J Int Neuropsychol Soc | 2024 |
| 37918374 | Timing of Cognitive Test Score Decline Prior to Incident Dementia Diagnosis in Blacks and Whites: The Atherosclerosis Risk in Communities Neurocognitive Study. | Neuroepidemiology | 2024 |
| 37963289 | Modeling the temporal evolution of plasma p-tau in relation to amyloid beta and tau PET. | Alzheimers Dement | 2024 |
| 37804318 | Synthesizing images of tau pathology from cross-modal neuroimaging using deep learning. | Brain | 2024 |
| 38014536 | Mayo normative studies: regression-based normative data for ages 30-91 years with a focus on the Boston Naming Test, Trail Making Test and Category Fluency. | J Int Neuropsychol Soc | 2024 |
| 37831661 | Uncovering the distinct macro-scale anatomy of dysexecutive and behavioural degenerative diseases. | Brain | 2024 |
| 37932910 | Vascular risk, gait, behavioral, and plasma indicators of VCID. | Alzheimers Dement | 2024 |
| 38091751 | Neurite-based white matter alterations in MAPT mutation carriers: A multi-shell diffusion MRI study in the ALLFTD consortium. | Neurobiol Aging | 2024 |
| 35142047 | Association between CSF biomarkers of Alzheimer's disease and neuropsychiatric symptoms: Mayo Clinic Study of Aging. | Alzheimers Dement | 2023 |
| 38025797 | Association of Cerebrovascular Imaging Biomarkers, Depression, and Anxiety, with Mild Cognitive Impairment. | J Alzheimers Dis Rep | 2023 |
| 37529120 | Plasma-derived biomarkers of Alzheimer's disease and neuropsychiatric symptoms: A community-based study. | Alzheimers Dement (Amst) | 2023 |
| 37703605 | Effects of de-facing software mri_reface on utility of imaging biomarkers used in Alzheimer's disease research. | Neuroimage Clin | 2023 |
| 37586881 | Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging. | Neurology | 2023 |
| 37478886 | Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial. | Lancet | 2023 |
| 37886506 | Advancing Tau-PET quantification in Alzheimer's disease with machine learning: introducing THETA, a novel tau summary measure. | Res Sq | 2023 |
| 37580163 | Association of Plasma Biomarkers of Alzheimer Disease With Cognition and Medical Comorbidities in a Biracial Cohort. | Neurology | 2023 |
| 37986913 | Boston criteria v2.0 for cerebral amyloid angiopathy without hemorrhage: An MRI-neuropathological validation study. | medRxiv | 2023 |
| 37541842 | Association of Plasma Aβ<sub>42</sub>/Aβ<sub>40</sub> Ratio and Late-Onset Epilepsy: Results From the Atherosclerosis Risk in Communities Study. | Neurology | 2023 |
| 38045300 | A limbic-predominant amnestic neurodegenerative syndrome associated with TDP-43 pathology. | medRxiv | 2023 |
| 37605276 | TDP-43-regulated cryptic RNAs accumulate in Alzheimer's disease brains. | Mol Neurodegener | 2023 |
| 37638398 | Cerebral Microbleed Patterns and Cortical Amyloid-β: The ARIC-PET Study. | Stroke | 2023 |
| 37563165 | Frontotemporal lobar degeneration. | Nat Rev Dis Primers | 2023 |
| 35640170 | Relationships of Cerebral Perfusion With Gait Speed Across Systolic Blood Pressure Levels and Age: A Cohort Study. | J Gerontol A Biol Sci Med Sci | 2023 |
| 35596270 | Physical Frailty and Brain White Matter Abnormalities: The Atherosclerosis Risk in Communities Study. | J Gerontol A Biol Sci Med Sci | 2023 |
| 36948153 | Lecanemab reduces brain amyloid-β and delays cognitive worsening. | Cell Rep Med | 2023 |
| 37419460 | Hearing, β-Amyloid Deposition and Cognitive Test Performance in Black and White Older Adults: The ARIC-PET Study. | J Gerontol A Biol Sci Med Sci | 2023 |
| 37248223 | Evidence against a temporal association between cerebrovascular disease and Alzheimer's disease imaging biomarkers. | Nat Commun | 2023 |
| 37279785 | Genetic risk scores enhance the diagnostic value of plasma biomarkers of brain amyloidosis. | Brain | 2023 |
| 37013176 | Default mode network failure and neurodegeneration across aging and amnestic and dysexecutive Alzheimer's disease. | Brain Commun | 2023 |
| 36973045 | Brain Shrinkage in Anti-β-Amyloid Alzheimer Trials: Neurodegeneration or Pseudoatrophy? | Neurology | 2023 |
| 37269958 | A face-off of MRI research sequences by their need for de-facing. | Neuroimage | 2023 |
| 37269398 | Plasma biomarkers for prediction of Alzheimer's disease neuropathologic change. | Acta Neuropathol | 2023 |
| 37202168 | β-Amyloid Load on PET Along the Continuum of Dementia With Lewy Bodies. | Neurology | 2023 |
| 37268436 | Clinicoradiologic and Neuropathologic Evaluation of Corticobasal Syndrome. | Neurology | 2023 |
| 37068958 | White Matter Degeneration Pathways Associated With Tau Deposition in Alzheimer Disease. | Neurology | 2023 |
| 37295957 | Implications of the Approval of Lecanemab for Alzheimer Disease Patient Care: Incremental Step or Paradigm Shift? | Neurology | 2023 |
| 37163045 | Creating the Pick's disease International Consortium: Association study of <i>MAPT</i> H2 haplotype with risk of Pick's disease. | medRxiv | 2023 |
| 36789483 | Predicting amyloid PET and tau PET stages with plasma biomarkers. | Brain | 2023 |
| 36721911 | Deciphering the clinico-radiological heterogeneity of dysexecutive Alzheimer's disease. | Cereb Cortex | 2023 |
| 36696808 | Differential effect of dementia etiology on cortical stiffness as assessed by MR elastography. | Neuroimage Clin | 2023 |
| 36443011 | Cross-sectional Associations of β-Amyloid, Tau, and Cerebrovascular Biomarkers With Neurodegeneration in Probable Dementia With Lewy Bodies. | Neurology | 2023 |
| 36808817 | Dementia occurring over a 32-year follow-up attributable to hypertension observed at different ages: Implications for dementia prevention. | Alzheimers Dement | 2023 |
| 36744338 | Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease. | J Alzheimers Dis | 2023 |
| 36806507 | Associations of Neurodegeneration Biomarkers in Cerebrospinal Fluid with Markers of Alzheimer's Disease and Vascular Pathology. | J Alzheimers Dis | 2023 |
| 36909142 | Interactions Between Neuropsychiatric Symptoms and Alzheimer's Disease Neuroimaging Biomarkers in Predicting Longitudinal Cognitive Decline. | Psychiatr Res Clin Pract | 2023 |
| 36464975 | Mid- and Late-Life Physical Activity and Neuropsychiatric Symptoms in Dementia-Free Older Adults: Mayo Clinic Study of Aging. | J Neuropsychiatry Clin Neurosci | 2023 |
| 36463537 | TDP-43 pathology effect on volume and flortaucipir uptake in Alzheimer's disease. | Alzheimers Dement | 2023 |
| 36463445 | Late Midlife Subclinical Infarct Burden and Risk of Dementia: The Atherosclerosis Risk in Communities Neurocognitive Study. | J Alzheimers Dis | 2023 |
| 36737114 | Population-Based Evaluation of Total Protein in Cerebrospinal Fluid. | Mayo Clin Proc | 2023 |
| 36731814 | Cross-scanner harmonization methods for structural MRI may need further work: A comparison study. | Neuroimage | 2023 |